Since 2001, GenoScreen is a pioneer of the use of sequencing, genotyping and bioinformatics. Its innovative genomics services and products address the needs of research groups in academia and industry.
GenoScreen also runs in-house innovation programs that fuel its technological lead and generate highly accurate, high-quality services and products.
More than
20
years of expertise in genomics
and bioinformatics
More than
300
service and expertise active customers
27
research partners and competitiveness clusters worldwide
More than
40
customer countries for antibiotic resistance diagnostic Deeplex® kits for tuberculosis
Cutting-edge services in genomics, metagenomics and bioinformatics
GenoScreen offers a broad set of services in genomics, metagenomics and bioinformatics, based on high-powered technology platforms.
The company has been serving a wide range of customers for over 15 years.
A stakeholder in microbiology research and innovation
GenoScreen is involved in many private- and public-sector research programs. It is developing a portfolio of analytical and monitoring tools in genomics, metagenomics and molecular microbiology.
Benefiting humankind and the environment
The services and innovations developed by GenoScreen address the needs of academic and industry-based researchers tackling a variety of issues in human health and environmental protection.
Our values
- A pioneering spirit: staying at the cutting edge of technology and innovation
- The ambition: to see our employees and customers grow and develop
- Proximity and respect for our customers and partners
- A start-up spirit: staying as enthusiastic as when we started
Accreditations and awards
- Label bpifrance Excellence 2023 awarded by bpifrance for the growth path.
- Label ePitches Euroquity 2017 awarded by bpifrance, enables the best start-ups to present their projects.
- Label Talents INPI Hauts-de-France 2016 Innovation category.
- Winner 2016, Initiative PME for the BIMM-SOL project, awarded by ADEME.
- Member of the Oséo Excellence Community, a group of 2,000 companies selected for their growth potential.
- Member of the bpifrance community "Les Accélérés".
- Member of the Adebiotech Think Tank.